Literature DB >> 29889762

Feasibility of Complete Salpingectomy Compared With Standard Postpartum Tubal Ligation at Cesarean Delivery: A Randomized Controlled Trial.

Akila Subramaniam1, Christina T Blanchard, Britt K Erickson, Jeff Szychowski, Charles A Leath, Joseph R Biggio, Warner K Huh.   

Abstract

OBJECTIVE: To evaluate the feasibility of salpingectomy compared with standard bilateral tubal ligation at the time of cesarean delivery in women with undesired fertility.
METHODS: We included women at 35 weeks of gestation or greater desiring permanent sterilization at the time of cesarean delivery. Patients were randomized after skin incision to bilateral salpingectomy or bilateral tubal ligation by a computer-generated scheme. If salpingectomy could not be completed on one or both sides, bilateral tubal ligation was attempted. Primary feasibility outcomes were total operative time and bilateral completion of the randomized procedure. Secondary outcomes included clinically estimated blood loss and surgical complications up to 6 weeks postpartum. We estimated that 80 patients (40 per group) would provide greater than 80% power to identify a 10-minute difference in the primary outcome (time) with a SD of 15 minutes and a two-sided α of 0.05. Analysis was by intent to treat.
RESULTS: Of 221 women screened from June 2015 to April 2017, 115 (52%) consented to the study; 80 were randomized-40 to salpingectomy and 40 to bilateral tubal ligation. Groups were similar at baseline. A total of 27 bilateral salpingectomies were successfully completed compared with 38 bilateral tubal ligations (68% compared with 95%, P=.002). Total operative time was on average 15 minutes longer for salpingectomies (75.4±29.1 compared with 60.0±23.3 minutes, P=.004). No adverse outcomes directly related to the sterilization procedure were noted in either group. Although estimated blood loss of only the sterilization procedure (surgeon estimate) was greater for the salpingectomy group (median 10 [interquartile range 5-25] compared with 5 [interquartile range 5-10] cc, P<.001), total estimated blood loss and safety outcomes were similar for both groups.
CONCLUSION: Adding 15 minutes to total operative times, salpingectomy can be successfully completed in approximately two thirds of women desiring permanent contraception with cesarean delivery. CLINICAL TRIAL REGISTRATION: Clinicaltrials.gov, NCT02374827.

Entities:  

Mesh:

Year:  2018        PMID: 29889762      PMCID: PMC6019146          DOI: 10.1097/AOG.0000000000002646

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  22 in total

1.  Surgical outcomes and complications of prophylactic salpingectomy at the time of benign hysterectomy in premenopausal women.

Authors:  Lucas Minig; Linus Chuang; María Guadalupe Patrono; José Miguel Cárdenas-Rebollo; Jesús García-Donas
Journal:  J Minim Invasive Gynecol       Date:  2015-02-24       Impact factor: 4.137

2.  Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: Evidence for a causal relationship.

Authors:  David W Kindelberger; Yonghee Lee; Alexander Miron; Michelle S Hirsch; Colleen Feltmate; Fabiola Medeiros; Michael J Callahan; Elizabeth O Garner; Robert W Gordon; Chandler Birch; Ross S Berkowitz; Michael G Muto; Christopher P Crum
Journal:  Am J Surg Pathol       Date:  2007-02       Impact factor: 6.394

3.  The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory.

Authors:  Robert J Kurman; Ie-Ming Shih
Journal:  Am J Surg Pathol       Date:  2010-03       Impact factor: 6.394

4.  Costs and benefits of opportunistic salpingectomy as an ovarian cancer prevention strategy.

Authors:  Janice S Kwon; Jessica N McAlpine; Gillian E Hanley; Sarah J Finlayson; Trevor Cohen; Dianne M Miller; C Blake Gilks; David G Huntsman
Journal:  Obstet Gynecol       Date:  2015-02       Impact factor: 7.661

5.  Committee opinion no. 620: Salpingectomy for ovarian cancer prevention.

Authors: 
Journal:  Obstet Gynecol       Date:  2015-01       Impact factor: 7.661

Review 6.  The role of the fallopian tube in the origin of ovarian cancer.

Authors:  Britt K Erickson; Michael G Conner; Charles N Landen
Journal:  Am J Obstet Gynecol       Date:  2013-04-10       Impact factor: 8.661

7.  Opportunistic salpingectomy: uptake, risks, and complications of a regional initiative for ovarian cancer prevention.

Authors:  Jessica N McAlpine; Gillian E Hanley; Michelle M M Woo; Alicia A Tone; Nirit Rozenberg; Kenneth D Swenerton; C Blake Gilks; Sarah J Finlayson; David G Huntsman; Dianne M Miller
Journal:  Am J Obstet Gynecol       Date:  2014-01-09       Impact factor: 8.661

8.  Total bilateral salpingectomy versus partial bilateral salpingectomy for permanent sterilization during cesarean delivery.

Authors:  Shiri Shinar; Yair Blecher; Sharon Alpern; Ariel Many; Eran Ashwal; Uri Amikam; Aviad Cohen
Journal:  Arch Gynecol Obstet       Date:  2017-03-11       Impact factor: 2.344

9.  3 to 5 Years Later: Long-term Effects of Prophylactic Bilateral Salpingectomy on Ovarian Function.

Authors:  Roberta Venturella; Daniela Lico; Massimo Borelli; Maria G Imbrogno; Gabriele Cevenini; Errico Zupi; Fulvio Zullo; Michele Morelli
Journal:  J Minim Invasive Gynecol       Date:  2016-09-13       Impact factor: 4.137

10.  Prophylactic bilateral salpingectomy (PBS) to reduce ovarian cancer risk incorporated in standard premenopausal hysterectomy: complications and re-operation rate.

Authors:  J Vorwergk; M P Radosa; K Nicolaus; N Baus; J Jimenez Cruz; M Rengsberger; M Gajda; H Diebolder; I B Runnebaum
Journal:  J Cancer Res Clin Oncol       Date:  2014-02-27       Impact factor: 4.553

View more
  7 in total

Review 1.  Biomaterials and Contraception: Promises and Pitfalls.

Authors:  Isabella Claure; Deborah Anderson; Catherine M Klapperich; Wendy Kuohung; Joyce Y Wong
Journal:  Ann Biomed Eng       Date:  2019-11-07       Impact factor: 3.934

2.  The cost-effectiveness of opportunistic salpingectomy versus standard tubal ligation at the time of cesarean delivery for ovarian cancer risk reduction.

Authors:  Akila Subramaniam; Brett D Einerson; Christina T Blanchard; Britt K Erickson; Jeff Szychowski; Charles A Leath; Joseph R Biggio; Warner K Huh
Journal:  Gynecol Oncol       Date:  2018-11-23       Impact factor: 5.482

3.  Patients' perceptions toward and the driving factors of decision-making for opportunistic bilateral salpingectomy at the time of cesarean section.

Authors:  Murat Yassa; Çiğdem Pulatoğlu
Journal:  Turk J Obstet Gynecol       Date:  2020-07-29

4.  Bilateral salpingectomy versus bilateral partial salpingectomy during cesarean delivery.

Authors:  Jose R Duncan; Heather L Jones; Stefanie O Hoffer; Mauro H Schenone; Giancarlo Mari
Journal:  Int J Womens Health       Date:  2018-10-23

5.  Relationship between the precursors of high grade serous ovarian cancer and patient characteristics: decreased incidence of the p53 signature in pregnant women.

Authors:  Tsutomu Ida; Hiroyuki Fujiwara; Takahiro Kiriu; Yoshimi Taniguchi; Akira Kohyama
Journal:  J Gynecol Oncol       Date:  2019-11       Impact factor: 4.401

Review 6.  Surgically Induced Menopause-A Practical Review of Literature.

Authors:  Cristina Secoșan; Oana Balint; Laurențiu Pirtea; Dorin Grigoraș; Ligia Bălulescu; Răzvan Ilina
Journal:  Medicina (Kaunas)       Date:  2019-08-14       Impact factor: 2.430

Review 7.  Bilateral salpingectomy to reduce the risk of ovarian/fallopian/peritoneal cancer in women at average risk: a position statement of the Korean Society of Obstetrics and Gynecology (KSOG).

Authors:  Miseon Kim; Young-Han Kim; Yong Beom Kim; Jayeon Kim; Jae-Weon Kim; Mi Hye Park; Joo Hyun Park; Jeong Ho Rhee; Myong Cheol Lim; Joon-Seok Hong
Journal:  Obstet Gynecol Sci       Date:  2018-09-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.